Rocket Lab (RKLB) stock fell 30% from May highs despite record Q1 revenue, Nasdaq-100 entry, and a $2.2B backlog. Here's what investors need to know. The post RocketRocket Lab (RKLB) stock fell 30% from May highs despite record Q1 revenue, Nasdaq-100 entry, and a $2.2B backlog. Here's what investors need to know. The post Rocket

Rocket Lab (RKLB) Stock Drops 30% Despite Record Q1 Results and Nasdaq-100 Entry

2026/06/18 23:36
4 min read
For feedback or concerns regarding this content, please contact us at crypto.news@mexc.com

Key Highlights

  • RKLB shares have declined approximately 30% from their late-May peak, currently hovering near $107.98
  • First quarter revenue reached an all-time high of $200.35 million, representing a 63.4% year-over-year increase and surpassing analyst projections
  • The company will be added to the Nasdaq-100 index on June 22, potentially increasing institutional buying pressure
  • Institutional investors now control 71.78% of outstanding shares, with Capital Impact Advisors expanding its position by 47.5%
  • Analyst consensus reflects a “Moderate Buy” recommendation with an average price target of $102.76

Rocket Lab has experienced significant downward pressure following SpaceX’s highly-publicized IPO announcement, with RKLB shares retreating nearly 30% from their late-May peak of approximately $151.00. The stock began Thursday’s session at $107.98, maintaining support above its 50-day moving average of $104.00 while remaining substantially below recent highs.


RKLB Stock Card
Rocket Lab USA, Inc., RKLB

Despite this price decline, the company’s operational performance continues to demonstrate strength. First quarter revenue reached $200.35 million, establishing a new quarterly record and representing a 63.4% increase compared to the prior year period. This performance exceeded Wall Street’s consensus estimate of $189.65 million.

Gross profit margins also achieved a record level of 38.2% during Q1, indicating enhanced operational efficiency as the business expands. The company’s order backlog currently stands at $2.2 billion, providing substantial revenue visibility for upcoming periods.

Executives have projected another record-breaking performance for Q2, extending a pattern that indicates Rocket Lab is experiencing sustainable expansion rather than temporary momentum.

Government Contracts Expanding Revenue Streams

Beyond its core launch operations, Rocket Lab is building a significant presence in the defense sector. The company won a substantial $515 million contract from the Space Development Agency in 2024 for satellite manufacturing, establishing its credentials as a primary contractor for U.S. government programs.

Additionally, the firm secured a $30 million agreement with Anduril Industries to deploy its HASTE vehicle for hypersonic testing missions launching from Virginia’s Launch Complex 2. These government agreements are diversifying revenue sources beyond the company’s traditional commercial small-satellite launch business.

Rocket Lab’s Electron vehicle maintains its position as the world’s most frequently launched small-class rocket, executing between 10 and 15 missions annually. Its closest competitor in this market segment is China’s Galactic Energy with the Ceres-1 rocket.

In a significant commercial win last month, the company announced its largest bulk-purchase agreement to date—five Neutron rocket launches contracted before the vehicle has completed its maiden flight.

Index Addition and Institutional Positioning

Rocket Lab’s inclusion in the Nasdaq-100 index takes effect on June 22. This development represents a potentially significant catalyst, as index additions generally trigger mandatory purchases from passive investment vehicles that track the benchmark.

Capital Impact Advisors expanded its holdings by 47.5% during the fourth quarter, acquiring an additional 145,741 shares to reach a total position of 452,728 units. Institutional investors collectively own 71.78% of the company’s shares.

Regarding insider transactions, SVP Arjun Kampani divested 23,804 shares at $147.43 on May 28, while insider Marvin Bradford Clevenger sold 3,500 shares at $146.67 on the same date. Company insiders have collectively sold approximately $66.9 million in stock during the past three months.

Valuation metrics present a challenge for the investment thesis. RKLB currently trades at a forward price-to-sales ratio of approximately 68x, representing a premium of more than 3,500% above the sector median. Such elevated multiples are typically associated with high-margin software companies rather than hardware-focused businesses operating at 38% gross margins.

The Neutron rocket, a medium-lift vehicle that appears heavily weighted in current valuations, has yet to complete its first mission. A tank testing setback has delayed the inaugural launch to the fourth quarter of 2026, maintaining execution uncertainty.

TD Cowen and Needham both elevated their price objectives to $120 with Buy recommendations following the Q1 earnings release. KGI Securities launched coverage on June 11 with a Neutral stance and a $105 price target. The consensus analyst price target currently sits at $102.76.

The post Rocket Lab (RKLB) Stock Drops 30% Despite Record Q1 Results and Nasdaq-100 Entry appeared first on Blockonomi.

Market Opportunity
LAB Logo
LAB Price(LAB)
$17.88868
$17.88868$17.88868
+12.14%
USD
LAB (LAB) Live Price Chart

World Cup Combo: Aim for 200x

World Cup Combo: Aim for 200xWorld Cup Combo: Aim for 200x

Combine up to 20 World Cup matches in one order

Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact crypto.news@mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

Score Your Share of 50K USDT

Score Your Share of 50K USDTScore Your Share of 50K USDT

Complete DEX+ tasks to unlock the Champion Wheel